Aging induces a decrease in bone mass. Osteoporosis with its accompanying decrease in bone mass is widely recognized as a major public health problem. The most dramatic expression of the disease is represented by fractures of the proximal femurs. [1] [2] [3] A decrease in bone mass may be due to decreased bone formation and increased bone resorption. Pharmacological and nutritional factors may prevent bone loss with increasing age. 4, 5) Chemical compounds in food that act on bone metabolism, however, are poorly understood.
physeal or -metaphyseal fragments were cultured for 48 h in 35 mm dishes in 2.0 ml medium consisting of Dulbecco's MEM (high glucose, 4.5 g/dl) supplemented with 0.25% BSA plus antibiotics (100 units of penicillin and 100 mg of streptomycin/ml of medium). 22) The culture medium did not contain zinc. In experiments, bone tissues were cultured for 48 h in a medium containing either vehicle or compound (including 0.1% ethanol). Cultures were maintained at 37°C in a water-saturated atmosphere containing 5% CO 2 and 95% air.
Analytical Procedures The diaphyseal and metaphyseal tissues were dried for 16 h at 110°C. Calcium was determined by atomic absorption spectrophotometry. 22) Calcium content in bone tissues is expressed as milligrams per gram of dry bone.
To assay alkaline phosphatase activity, the diaphyseal and metaphyseal tissues were immersed in 3.0 ml of ice-cold 6.5 mM barbital (pH 7.4), cut into small pieces, homogenized with a physcotron homogenizer, and disrupted for 60 s with an ultrasonic device. 23) The supernatant centrifuged at 600ϫ g for 5 min was used to measure enzyme activity. Enzyme assay was carried out under optimal conditions. Alkaline phosphatase activity was determined by the method of Walter and Schutt. 23 24) To measure bone DNA content, the diaphyseal and metaphyseal tissues were shaken with 4.0 ml of ice-cold 0.1 M NaOH solution for 24 h after homogenization of the bone tissues. 25) After alkali extraction, the samples were centrifuged at 10000ϫg for 5 min, and the supernatant was collected. DNA content in the supernatant was determined using the method of Ceriotti, 26) and expressed as the amount of DNA (mg)/g wet weight of bone tissue.
Statistical Analysis The significance of the difference between values was estimated by Student's t-test or by analysis of variance (ANOVA) for comparing multiple groups. A p value of less than 0.05 was considered to indicate statistically significant differences.
RESULTS
The effect of b-cryptoxanthin and zinc sulfate (zinc) on calcium content in femoral-diaphyseal (cortical bone) and -metaphyseal (trabecular bone) tissues of rats in vitro is shown in Fig. 1 . Bone tissues were cultured for 48 h in a serum-free medium containing either vehicle, b-cryptoxanthin (10 while their concentration did not have a significant effect on bone calcium content, caused a remarkable elevation in calcium content in the femoral-diaphyseal and -metaphyseal tissues. The synergistic effect with the two compounds on bone calcium content was also observed in the combination of bcryptoxanthin (10 Ϫ8 M) and zinc (10
The effect of combination with b-cryptoxanthin and other factors on calcium content in the femoral-diaphyseal and -metaphyseal tissues of rats in vitro is shown in Table 1 in increasing the calcium content in femoral-diaphyseal and -metaphyseal tissues in vitro was completely prevented in the presence of cycloheximide (10 Ϫ6 M) or DRB (10 Ϫ6 M) (Fig.  2) .
The combination of b-cryptoxanthin (10 Ϫ9 M) plus zinc (10 Ϫ6 M) caused a remarkable increase in alkaline phosphatase activity (Fig. 3) or DNA content (Fig. 4) in femoraldiaphyseal and -metaphyseal tissue in vitro. b-Cryptoxanthin (10 Ϫ9 M) or zinc (10 Ϫ6 M) alone did not have a significant effect on alkaline phosphatase activity or DNA content in femoral tissues. The synergistic effect of b-cryptoxanthin (10 Ϫ9 M) plus zinc (10 Ϫ6 M) in increasing alkaline phosphatase activity (Fig. 3) and DNA content (Fig. 4) in femoral-diaphyseal and -metaphyseal tissues was completely prevented in the presence of cycloheximide (10 Ϫ6 M) or DRB (10 Ϫ6 M).
DISCUSSION
Bone loss with increasing age induces osteoporosis, which is widely recognized as a major public health problem. [1] [2] [3] Food factors may play a role in the prevention of bone loss with aging. Carotenoids are present in large quantities in food and plants. Of the various carotenoids, b-cryptoxanthin had a unique stimulatory effect on calcium content and alkaline phosphatase activity in rat femoral-diaphyseal (cortical bone) and -metaphyseal (trabecular bone) tissues in vitro. 6) Meanwhile, zinc has a potent stimulatory effect on bone formation among various trace metals.
27) It was found that the combination of b-cryptoxanthin and zinc of a comparatively lower concentration, at which their concentration did not have a significant effect on bone components, induces a remarkable elevation of calcium content, alkaline phosphatase activity, and DNA content in rat femoral-diaphyseal and -metaphyseal tissues in vitro. The combination of b-cryptoxanthin and zinc had a potent anabolic effect on bone components in the cortical bone and trabecular bone. Trabecular bone is easily resorbed by various bone-resorbing factors. This finding suggests that the combination of b-cryptoxanthin and zinc has potentiality in the prevention of bone loss with aging.
The synergistic effect of nutritional factors on bone components was not observed in the combination of b-cryptoxanthin and other food factors (including genistein or menaquinone-7) which have an anabolic effect on bone metabolism. 28, 29) Genistein 30) or menaquinone-7 31) has a stimulatory effect on osteoblastic bone formation. The synergistic effect was also not seen in the combination of zinc plus genistein or menaquinone-7, with their lower concentrations in femoral tissues in vitro. Thus, the synergistic effect with the combination of b-cryptoxanthin and zinc at a lower concentration on bone calcium content was unique.
The effect of the combination of b-cryptoxanthin and zinc in increasing the calcium content, alkaline phosphatase activity, and DNA content in rat femoral tissues was completely prevented in the presence of cycloheximide, an inhibitor of protein synthesis, or DRB, an inhibitor of transcriptional activity. Alkaline phosphatase is an enzyme marker of osteoblasts, and the enzyme participates in bone mineralization.
32) The DNA content in bone tissues is an index of the number of bone cells.
33) The present results suggest that the synergistic effect of the combination of b-cryptoxanthin and zinc on bone components requires newly synthesized protein components.
b-Cryptoxanthin has been suggested to have an effect on nuclear factors to stimulate transcriptional activity in os- teoblastic cells. 8, 9) Meanwhile, zinc has been demonstrated to activate aminoacyl-tRNA synthase, a rate limiting enzyme of protein synthesis of the translational process, in osteoblastic cells. 34) It is speculated that the combination of b-cryptoxanthin and zinc has a stimulatory effect on both gene expression and protein synthesis in osteoblastic cells. This may induce a synergistic effect on bone components in bone tissues.
Chemical factors in food may help to prevent bone loss with aging. Supplemental intake of a combination of b-cryptoxanthin and zinc may be useful as a tool in the prevention of osteoporosis. This remains to be elucidated using an animal model for osteoporosis.
In conclusion, it has been demonstrated, for the first time to the best of our knowledge, that the combination of b-cryptoxanthin and zinc with lower concentrations has a synergistic-anabolic effect on bone components in the femoral-diaphyseal and -metaphyseal tissues of rats in vitro.
